首页 | 本学科首页   官方微博 | 高级检索  
检索        

PNH患者骨髓CD34^+CD59^+细胞体外扩增及植入体内重建造血的活性研究
引用本文:钟玉萍,武永吉,沈悌,汪玄,张洁萍.PNH患者骨髓CD34^+CD59^+细胞体外扩增及植入体内重建造血的活性研究[J].中国实验血液学杂志,2008,16(3):561-564.
作者姓名:钟玉萍  武永吉  沈悌  汪玄  张洁萍
作者单位:1. 首都医科大学附属北京朝阳医院(京西院区)血液与肿瘤科,北京,100043
2. 中国医学科学院、北京协和医学院北京协和医院血液科,北京,100730
摘    要:本研究应用BALB/c裸鼠为移植模型探讨阵发性睡眠性血红蛋白尿症(paroxysmal nocturnal hemoglobin—uria,PNH)患者CD34^+CD59^+的增殖和重建造血的能力,为实现PNH患者自体骨髓移植或自体外周血造血干细胞移植提供实验依据。利用免疫磁珠双阳性分选法,从正常人及PNH患者骨髓中分离出两组CD34^+CD59^+细胞,分别进行体外扩增,并将体外扩增的正常人和PNH患者骨髓CD34^+CD59^+细胞分别输注给接受亚致死剂量照射的BALB/c裸鼠。应用流式细胞技术和DNA检测技术检测受鼠骨髓、脾脏和外周血中人CD45^+细胞。结果表明:PNH组的CD34^+CD59^+细胞在体外生存、扩增能力似弱于正常人对照组。但CD34^+CD59^+细胞输注给受鼠后6周,在受鼠骨髓、脾脏和外周血中可检测到人CD45^+细胞,PNH组受鼠CD45^+细胞水平与正常人对照组相比,无统计学差异。结论:PNH患者CD34^+CD59^+细胞仍具有同正常人CD34^+CD59^+细胞相同的生物特性,能体外扩增并能保持正常干/祖细胞的特性。

关 键 词:阵发性睡眠性血红蛋白尿症  CD34^+CD59^+细胞  细胞扩增
文章编号:1009-2137(2008)03-0561-04
修稿时间:2007年8月27日

Ex Vivo Expansion of CD34+ CD59+ Cells from Patients with Paroxysmal Nocturnal Hemoglobinuria and Their Hematopoietic Reconstitution Capa-bility in Irradiated Nude Mice
ZHONG Yu-Ping,WU Yong-Ji,SHEN Ti,WANG Xuan,ZHANG Jie-Ping.Ex Vivo Expansion of CD34+ CD59+ Cells from Patients with Paroxysmal Nocturnal Hemoglobinuria and Their Hematopoietic Reconstitution Capa-bility in Irradiated Nude Mice[J].Journal of Experimental Hematology,2008,16(3):561-564.
Authors:ZHONG Yu-Ping  WU Yong-Ji  SHEN Ti  WANG Xuan  ZHANG Jie-Ping
Institution:Department of Hematology, Beijing Chaoyang Hospital (Jingxi Campus), Capital University of Medical Sciences Bejing 100043, China.
Abstract:This study was purposed to investigate the expansion and hematopoietic reconstitution capability of CD34(+)CD59(+) cells from patients with paroxysmal nocturnal hemoglobinuria (PNH) by using BALB/c nude mice so as to provide experimental basis for clinical anto-BMT or auto-PBHSCT in patients with PNH. CD34(+)CD59(+) cells were selected from the bone marrow mononuclear cells in normal persons and PNH patients by immunomagnetic positive double sorting and were engrafted sublethally irradiated BALB/c nude mice. The human CD45(+) cells in bone marrow, spleen and peripheral blood of recipient mice were detected by flow cytometry and DNA assay. The results showed that the CD34(+)CD59(+) cells in PNH patient group and normal person group could expanded ex vivo, but ex vivo expansion capability of CD34(+)CD59(+) cells in PNH patient group at day 7 seemed inferior to that in normal control. While CD34(+)CD59(+) cells of PNH patients and normal persons were transfused into recipient mice, the human CD45(+) cells could be detected in bone marrow, spleen and peripheral blood at 6 weeks after transfusion, but there was no statistical difference in counts of CD45 cells between 2 groups. It is concluded that CD34(+)CD59(+) cells from PNH patients may keep characteristics of normal hematopoietic stem cells, and possess ability to expand ex vivo and support hemopoiesis.
Keywords:paroxysmal nocturnal hemoglobinuria  CD34 ^+CD59 ^+ cell  cell expansion
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号